Glutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis

Molecular Cancer Therapeutics

Volumn 10, Issue 1, 2011, Pages 16-28

  Singhal, Sharad S ^a   Wickramarachchi, Dilki ^b   Yadav, Sushma ^a   Singhal, Jyotsana ^a   Leake, Kathryn ^a   Vatsyayan, Rit ^a   Chaudhary, Pankaj ^a   Lelsani, Poorna ^a   Suzuki, Sumihiro ^a   Yang, Shaohua ^a   Awasthi, Yogesh C ^a   Awasthi, Sanjay ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BENZO[A]PYRENE; CLATHRIN; COMPLEMENTARY DNA; DIMETHYLBENZ[A]ANTHRACENE; EPIDERMAL GROWTH FACTOR; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE P38; MUTANT PROTEIN; PHORBOL ESTER; PHOSPHOPROTEIN; PROTEIN KINASE C ALPHA; PROTEIN P53; PROTEIN RLIP76; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; WNT5A PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVATION; FEMALE; GENETIC VARIABILITY; LUNG CARCINOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BINDING SITES; CARCINOGENS; CLATHRIN; DRUG RESISTANCE, NEOPLASM; ENDOCYTOSIS; FEMALE; GLUTATHIONE; GTPASE-ACTIVATING PROTEINS; HUMANS; MALE; MICE; MICE, KNOCKOUT; PROTEIN KINASE C-ALPHA; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78751529721     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-10-0699     Document Type: Article

References (50)

1. Awasthi S, Singhal SS, Sharma R, Zimniak P, Awasthi YC. Transport of glutathione-conjugates and chemotherapeutic drugs by RLIP76: a novel link between G-protein and tyrosine-kinase signaling and drug-resistance. Int J Cancer 2003;106:635-46.
2. Awasthi S, Singhal SS, Srivastava SK, Zimniak P, Bajpai KK, Saxena M, et al. Adenosine-triphosphate-dependent transport of doxorubicin, daunomyicn, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein. J Clin Invest 1994;93:958-65.
3. Huang Y. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy. Cancer Metastasis Rev 2007;26:183-201.
4. Yadav S, Zajac E, Singhal SS, Awasthi S. Linking stress-signaling, glutathione-metabolism, signaling pathways and xenobiotic-transporters. Cancer Metastasis Rev 2007;26:59-69.
5. Desbois-Mouthon C, Baron A, Blivet-Van Eggelpo€el MJ, Fartoux L, Venot C, Bladt F, et al. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma. Clin Cancer Res 2009;15: 5445-56.
6. Watabe T, Miyazone K. Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res 2009;19:103-115.
7. Guo Q, Manolopoulou M, Bian Y, Schilling AB, Tang WJ. Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme. J Mol Biol 2010;395: 430-43.
8. Baserga R, Peruzzi F, Reiss K. The IGF-1 receptor in cancer biology. Int J Cancer 2003;107:873-7.
9. Pollak M. Insulin and insulin-like growth factor signaling in neoplasia. Nat Rev Cancer 2008;8:915-28.
10. Iozzo RV, Eichstetter L, Danielson KG.Aberrant expressionof the growth factor Wnt-5a in human malignancy. Cancer Res 1995;55:3495-9.
11. Laniosz V, Holthusen KA, Meneses PI. Bovine papillomavirus type 1: from clathrin to caveolin. J Virol 2008;82:6288-98.
12. Matsuzaki T, Hanai S, Kishi H, Liu Z, Bao Y, Kikuchi A. Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathway. J Biol Chem 2002;277: 19008-18.
13. Zhang Y, Zhang B. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Mol Cancer Res 2008;6:1861-71.
14. Pedersen NM, Madshus IH, Haslekás C, Stang E. Geldanamycin-induced down-regulation of ErbB2 from the plasma membrane is clathrin dependent but proteasomal activity independent. Mol Cancer Res 2008;6:491-500.
15. Rini BI, Atkins MB. Resistance to targeted therapy in renal-cell carcinoma. Lancet Oncol 2009;10:992-1000.
16. Jakoby WB. The glutathione S-transferases: a group of multi-functional detoxification protein. Adv Enzymol Mol Biol 1978;46:383-414.
17. Awasthi YC, Sharma R, Singhal SS. Human glutathione S-transferases. Int J Biochem 1994;26:295-308.
18. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600. (Pubitemid 126635512)
19. Awasthi S, Cheng J, Singhal SS, Saini MK, Pandya U, Pikula S, et al. Novel function of human RLIP76: ATP-dependent transport of glutathione- conjugates and doxorubicin. Biochemistry 2000;39: 9327-34.
20. Stuckler D, Singhal J, Singhal SS, Yadav S, Awasthi YC, Awasthi S. RLIP76 transports vinorelbine and mediates drug-resistance in nonsmall cell lung cancer. Cancer Res 2005;65:991-8.
21. Singhal SS, Yadav S, Roth C, Singhal J. RLIP76: a novel glutathione-conjugate and multi-drug transporter. Biochem Pharmacol 2009;77:761-9.
22. Singhal SS, Yadav S, Drake K, Singhal J, Awasthi S. Hsf-1 and POB1 induce drug-sensitivity and apoptosis by inhibiting Ralbp1. J Biol Chem 2008;283:19714-29.
23. Quaroni A, Paul EC. Cytocentrin is a Ral-binding protein involved in the assembly and function of the mitotic-apparatus. J Cell Sci 1999;112:707-18.
24. Hu Y, Mivechi NF. HSF-1 interacts with Ral-binding-protein 1 in a stress-responsive, multi-protein complex with HSP90 in vivo. J Biol Chem 2003;278:17299-306.
25. Vatsyayan R, Lelsani P, Awasthi S, Singhal SS. RLIP76: a versatile transporter and an emerging target for cancer therapy. Biochem Pharmacol 2010;79:1699-705.
26. Awasthi S, Singhal SS, Yadav S, Singhal J, Drake K, Nadkar A, et al. RALBP1 is a major determinant of radiation sensitivity. Cancer Res 2005;65:6022-8.
27. Singhal SS, Yadav S, Singhal J, Awasthi YC, Awasthi S. Mitogenic and drug-resistance mediating effects of PKCα require RLIP76. Biochem Biophys Res Commun 2006;348:722-7.
28. Singhal J, Singhal SS, Yadav S, Warnke M, Yacoub A, Dent P, et al. RLIP76 in defense of radiation poisoning. Int J Rad Oncol Biol Phys 2008;72:553-61.
29. Singhal SS, Yadav S, Singhal J, Sahu M, Sehrawat A, Awasthi S. Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76. FEBS Lett 2008;582:3408-14.
30. Singhal SS, Wickramarachchi D, Singhal J, Yadav S, Awasthi YC, Awasthi S. Determinants of differential doxorubicin sensitivity between SCLC and NSCLC. FEBS Lett 2006;580:2258-64.
31. Singhal SS, Awasthi YC, Awasthi S. Regression of melanoma in a murine model by RLIP76-depletion. Cancer Res 2006;66:2354-60.
32. Singhal SS, Singhal J, Yadav S, Dwivedi S, Boor P, Awasthi YC, et al. Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76. Cancer Res 2007;67:4382-9.
33. Singhal SS, Singhal J, Yadav S, Sahu M, Awasthi YC, Awasthi S. RLIP76: a target for kidney cancer therapy. Cancer Res 2009;69:4244-51.
34. Singhal SS, Roth C, Leake K, Singhal J, Yadav S, Awasthi S. Regression of prostate cancer xenografts by RLIP76 depletion. Biochem Pharmacol 2009;77:1074-83.
35. Singhal SS, Sehrawat A, Sahu M, Singhal P, Vatsyayan R, Lelsani P, et al. RLIP76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer. Int J Cancer 2010;126:1327-38.
36. Chan KS, Sano S, Kiguchi K, Anders J, Komazawa N, Takeda J, et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest 2004;114:720-8.
37. Chan KS, Sano S, Kataoka K, Abel E, Carbajal S, Beltran L, et al. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis. Oncogene 2008;27:1087-94.
38. Rosse C, L'Hoste S, Offner N, Picard A, Camonis JH. RLIP76, an effector of the Ral-GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis. J Biol Chem 2003;278:30597-604.
39. Kariya K, Koyama S, Nakashima S, Oshiro T, Morinaka K, Kikuchi A. Regulation of complex formation of POB1/epsin/adaptor protein complex 2 by mitotic phosphorylation. J Biol Chem 2000;275:18399-406.
40. Hitchens TK, Mannervik B, Rule GS. Disorder-to-order transition of the active site of human class Pi glutathione transferase, GST P1-1. Biochemistry 2001;40:11660-9.
41. Chuang CC, Wu SH, Chiou SH, Chang GG. Homology modeling of cephalopod lens S-crystallin: a natural mutant of sigma-class glutathione transferase with diminished endogenous activity. Biophys J 1999;76:679-90.
42. Tomarev SI, Zinovieva RD, Guo K, Piatigorsky J. Squid glutathione S-transferase. Relationships with other glutathione S-transferases and S-crystallins of cephalopods. J Biol Chem 1993;268:4534-42.
43. Awasthi S, Cheng J, Singhal SS, Sharma R, Pandya U, Singh SV, et al. Functional reassembly of xenobiotic transport from the N-terminal and C-terminal domains of RLIP76 and identification of ATP binding sequences. Biochemistry 2001;40:4159-68.
44. Awasthi S, Bajpai KK, Singhal SS, Frenkel EP, Ansari GAS, Awasthi YC. The effect of glutathione S-transferases on interactions of glutathione and melphalan. Drug Metab Disp 1996;24:371-4.
45. Singhal SS, Yadav S, Singhal J, Drake K, Awasthi YC, Awasthi S. The Role of PKCα and RLIP76 in Transport-mediated Doxorubicin-resistance in Lung Cancer. FEBS Lett 2005;579:4635-41.
46. Singhal SS, Yadav S, Singhal J, Zajac E, Drake K, Awasthi YC, et al. Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin. Biochem Pharmacol 2005;70:481-8.
47. Sharma R, Haque AK, Awasthi S, Singh SV, Piper JT, Awasthi YC. Differential carcinogenicity of benzo(a) pyrene in male and female CD-1 mouse lung. J Toxicol Environ Health 1997;52:45-62.
48. Awasthi S, Singhal SS, Yadav S, Singhal J, Vatsyayan R, Zajac E, et al. A central role of RLIP76 in regulation of glycemic control. Diabetes 2010;59:714-25.
49. Cheng JZ, Sharma R, Yang Y, Singhal SS, Sharma A, Saini MK, et al. Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress. J Biol Chem 2001; 276:41213-23.
50. Michie AM, Nakagawa R. The link between PKCα regulation and cellular transformation. Immunol Lett 2005;96:155-62.